US6231615B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Enhanced visibility materials for implantation in hard tissue
Assignee: Neurotherm LLC
•
Filing: 1999-10-18
•
Granted: 2001-05-15
•
Expires: 2019-10-18
Abstract
Abstract An enhanced visibility composition for implantation from a remote source, so that the composition can be readily observed under fluoroscopy or other imaging techniques. The compositions include a biocompatible matrix, such as a hard tissue implant material for example, and radiopaque particles mixed in the matrix. The radiopaque particles have a particle size between about 120μ and 2200μ, more preferably about 350μ and 2200μ, even more preferably between about 450μ and 1600μ, and most preferably between about 570μ0 and 1150μ. Preferably the hard tissue implant and the radiopaque particles are formed or prepared in a slurry. Optionally, the enhanced visibility composition may further include additional radiopaque particles or contrast particles mixed in with the composition, which have a particle size between about 120μ and 350μ, preferably between about 120μ and 250μ.
Inventors
- 👤 Howard Preissman
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:29
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/56; A61B17/58; A61B17/68; A61B17/70; A61B17/7094; A61B17/7095; A61L; A61L24/00; A61L24/001; A61L27/00; A61L27/50; A61F; A61F2/00; A61F2/02; A61F2/28; A61F2/30; A61F2/3094; A61F2/30965; A61F2/44; A61F2/46; A61F2/4601; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/3008; A61F2250/00; A61F2250/0058; A61F2250/0096; A61F2250/0098; A61F2310/00; A61F2310/00005; A61F2310/00179; A61F2310/00293; A61F2310/00329; A61F2310/00353
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
83 words
A method of delivering enhanced visibility hard tissue implant material, the implant material including particles for contrast having a size up to about 350μ and tracer elements having a size between about 570μ and about 2200μ, said method comprising: flowing an amount of the implant material into a desired implantation site; viewing, via a medical imaging device, the tracer elements to discern the instantaneous placement of the implant material; and continuing delivery of the implant material if appropriate initial placement has been achieved.
Claim 2
Independent Claim
83 words
A method of delivering enhanced visibility hard tissue implant material, the implant material including particles for contrast having a size up to about 350μ and tracer elements having a size between about 570μ and about 2200μ, said method comprising: flowing an amount of the implant material into a desired implantation site; viewing, via a medical imaging device, the tracer elements to discern the instantaneous placement of the implant material; and continuing delivery of the implant material if appropriate initial placement has been achieved.
Claim 3
Dependent Claim
20 words
The method set forth in claim 1 , wherein the implant material is flowed into a site for effecting vertebroplasty.
Claim 4
Dependent Claim
23 words
The method as set forth in claim 1 , wherein said viewing the tracer elements comprises viewing the flow of the tracer elements.
Claim 5
Dependent Claim
27 words
The method as set forth in claim 1 , further comprising accessing an implantation site from a remote location with a delivery tool prior to said flowing.
Claim 6
Dependent Claim
12 words
The method of claim 1 , wherein said flowing is performed percutaneously.
Claim 7
Dependent Claim
18 words
The method of claim 5 , wherein the implant material is flowed into a site for effecting vertebroplasty.
Claim 8
Dependent Claim
62 words
The method of any of claim 1 - 6 wherein the hard tissue implant material comprises material selected from a group consisting of polymethyl methacrylate, hydroxyapatite, calcium phosphates, calcium sulfates, demineralized and mineralized bone particles, polyglycolic acid compounds and polylactic acid compounds, collagen and collagen derivatives, chitin and chitosan, oxides of silicon, oxides of sodium, oxides of calcium and oxides of phosphorous.
References Cited (Backward Citations)
US3701771A
Cited
US3882858A
Cited
US3919773A
Cited
US4288355A
Cited
US4373217A
Cited
US4364921A
Cited
US4404327A
Cited
US4341691A
Cited
US4610692A
Cited
US4554686A
Cited
US4637931A
Cited
US4791150A
Cited
US4728570A
Cited
WO1987005491A1
Cited
WO1987005492A1
Cited
US4966601A
Cited
US5015101A
Cited
US4900546A
Cited
US4837279A
Cited
US5571182A
Cited
US5304586A
Cited
US4969888A
Cited
US5112354A
Cited
WO1992004924A1
Cited
US6080801A
Cited
US5574075A
Cited
US5367002A
Cited
US5476880A
Cited
US5336699A
Cited
US5282861A
Cited
US5336263A
Cited
US5507813A
Cited
US5451406A
Cited
US5795922A
Cited
WO1997004657A1
Cited
US5681872A
Cited
US5792478A
Cited
US5676146A
Cited
US5676146B1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2004-05-14 | 2004-11-13 | 2005-05-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2008-05-14 | 2008-11-13 | 2009-05-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2012-05-14 | 2012-11-13 | 2013-05-15 | $7700.00 | Window Closed / Lapsed |